Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase assembly factor COX14 is a small, single-pass transmembrane protein localized in the inner mitochondrial membrane. It is an essential component of the MITRAC complex, which coordinates synthesis and early assembly of the mitochondrial-encoded COX1 subunit into cytochrome c oxidase (complex IV), the terminal enzyme of the electron transport chain. COX14 regulates negative feedback for translation of COX1, protects newly synthesized COX1 from turnover, and supports the assembly of a functional enzyme complex. Mutations in COX14 disrupt complex IV activity, leading to mitochondrial complex IV deficiency, a clinically heterogeneous disorder with neurological, muscular, and hepatic manifestations[1][2][3]. Key details: - COX14 is not a classical therapeutic target such as a receptor, enzyme, transporter, or ion channel. - No known drugs are currently reported to act directly on COX14. - Pathogenic variants result in severe mitochondrial diseases by impairing the assembly and function of complex IV of the mitochondrial electron transport chain[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase assembly factor COX14 (COX14).